Carcinoma, Squamous
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT02298595) | Julie E. Bauman, MD, MPH | 2016-08-01 |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma (NCT02549638) | Mayo Clinic | 2015-04-08 |
| A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment (NCT01497041) | Korean South West Oncology Group | 2011-02-01 |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer (NCT01445405) | National Cancer Institute (NCI) | 2008-02-05 |
| Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer (NCT00591149) | University of Kansas Medical Center | 2007-06-01 |
Track Carcinoma, Squamous automatically
Every clearance here is in the API, with alerts when new ones post.